tesidolumab (LFG316) - Novartis, MorphoSys
"#ASH21 Abstracts online Nov 4, 2021 --> https://t.co/3x032Uai5W @symplur @ASH_hematology" (@mtmdphd) Nov 5, 2021 
Hematological Disorders
https://twitter.com/mtmdphd/status/1456711072216453122
 
Nov 5, 2021
 
 
1952e449-0866-45cc-98df-251db089e6d9.jpg